<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00006460</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000068256</org_study_id>
    <secondary_id>UCMC-00021401</secondary_id>
    <secondary_id>NCI-V00-1626</secondary_id>
    <nct_id>NCT00006460</nct_id>
  </id_info>
  <brief_title>Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme</brief_title>
  <official_title>A Phase I/II Trial of Conformal Radiotherapy and Hyperbaric Oxygen for Patients With Newly Diagnosed Glioblastoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barrett Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Hyperbaric oxygen&#xD;
      may increase the effectiveness of radiation therapy. Combining hyperbaric oxygen with&#xD;
      radiation therapy may be an effective treatment for glioblastoma multiforme.&#xD;
&#xD;
      PURPOSE: Phase I/II trial to study the effectiveness of combining radiation therapy with&#xD;
      hyperbaric oxygen in treating patients who have newly diagnosed glioblastoma multiforme.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES: I. Determine the feasibility and toxicity of hyperbaric oxygen combined with&#xD;
      conformal radiotherapy in patients with newly diagnosed glioblastoma multiforme. II.&#xD;
      Determine the efficacy of this regimen in terms of radiographic tumor response, time to tumor&#xD;
      progression, and survival in these patients.&#xD;
&#xD;
      OUTLINE: Within 2 weeks after surgery, patients receive hyperbaric oxygen over 90 minutes&#xD;
      once daily, followed by conformal radiotherapy twice daily 5 days a week for 17 days in the&#xD;
      absence of unacceptable toxicity. Patients are followed within 2 weeks and then every 2&#xD;
      months thereafter.&#xD;
&#xD;
      PROJECTED ACCRUAL: A total of 5-10 patients will be accrued for this study within 1 year.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>August 2000</start_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <condition>Brain and Central Nervous System Tumors</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hyperbaric oxygen</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS: Histologically proven newly diagnosed glioblastoma multiforme&#xD;
        Measurable residual tumor by MRI after biopsy or craniotomy&#xD;
&#xD;
        PATIENT CHARACTERISTICS: Age: Over 18 Performance status: Karnofsky 70-100% Life&#xD;
        expectancy: More than 8 weeks Hematopoietic: Not specified Hepatic: Not specified Renal:&#xD;
        Not specified Pulmonary: No severe pulmonary disease (e.g., emphysema with carbon dioxide&#xD;
        retention) No untreated pneumothorax Other: Not pregnant or nursing Negative pregnancy test&#xD;
        Fertile patients must use effective contraception No other malignancy within the past 5&#xD;
        years except epithelial skin cancer No psychological, familial, sociological, or&#xD;
        geographical conditions that would preclude study No intractable seizure disorder&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior or&#xD;
        concurrent bleomycin Endocrine therapy: Not specified Radiotherapy: No prior cranial&#xD;
        radiotherapy Surgery: See Disease Characteristics Other: No other prior therapy, including&#xD;
        adjuvant therapy, for glioblastoma multiforme&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald E. Warnick, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Barrett Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barrett Cancer Center, The University Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2002</verification_date>
  <study_first_submitted>November 6, 2000</study_first_submitted>
  <study_first_submitted_qc>February 2, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2004</study_first_posted>
  <last_update_submitted>December 3, 2013</last_update_submitted>
  <last_update_submitted_qc>December 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2013</last_update_posted>
  <keyword>adult glioblastoma</keyword>
  <keyword>adult giant cell glioblastoma</keyword>
  <keyword>adult gliosarcoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioblastoma</mesh_term>
    <mesh_term>Nervous System Neoplasms</mesh_term>
    <mesh_term>Central Nervous System Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

